Patents by Inventor Anthony R. Imondi

Anthony R. Imondi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Formulation and method for treating neoplasms by inhalation
    Patent number: 6471943
    Abstract: A formulation, method, and apparatus for treating neoplasms such as cancer by administering a pharmaceutically effective amount of highly toxic composition by inhalation, wherein the composition is a non-encapsulated antineoplastic drug.
    Type: Grant
    Filed: December 30, 1997
    Date of Patent: October 29, 2002
    Assignee: Battelle Pulmonary Therapeutics, Inc.
    Inventors: Michael E. Placke, Anthony R. Imondi
  • Formulation and method for treating neoplasms by inhalation
    Publication number: 20020155066
    Abstract: A formulation, method, and apparatus for treating neoplasms such as cancer by administering a pharmaceutically effective amount of highly toxic composition by inhalation, wherein the composition is a non-encapsulated antineoplastic drug.
    Type: Application
    Filed: February 4, 2002
    Publication date: October 24, 2002
    Inventors: Michael E. Placke, Anthony R. Imondi, Michael J. Brooker, John E. Frye, Praful K. Shah, Douglas R. Flanagan, Maureen D. Donovan
  • Formulation and method for treating neoplasms by inhalation
    Patent number: 6451784
    Abstract: A formulation and method for treating neoplasms such as cancer by administering a pharmaceutically effective amount or carboplatin by inhalation.
    Type: Grant
    Filed: March 3, 2000
    Date of Patent: September 17, 2002
    Assignee: BattellePharma, Inc.
    Inventors: Michael E. Placke, Anthony R. Imondi, Praful K. Shah
  • Method for treating neoplasms by inhalation
    Patent number: 6419901
    Abstract: A formulation, method, and apparatus for treating neoplasms such as cancer by administering a pharmaceutically effective amount of highly toxic composition by inhalation, wherein the composition is a non-encapsulated antineoplastic drug.
    Type: Grant
    Filed: June 6, 2001
    Date of Patent: July 16, 2002
    Assignee: Battelle Pulmonary Therapeutics
    Inventors: Michael E. Placke, Anthony R. Imondi
  • Formulation and method for treating neoplasms by inhalation
    Patent number: 6419900
    Abstract: A formulation, method, and apparatus for treating neoplasms such as cancer by administering a pharmaceutically effective amount of highly toxic composition by inhalation, wherein the composition is a non-encapsulated antineoplastic drug.
    Type: Grant
    Filed: June 6, 2001
    Date of Patent: July 16, 2002
    Assignee: Battelle Pulmonary Therapeutics
    Inventors: Michael E. Placke, Anthony R. Imondi
  • Formulation and method for treating neoplasms by inhalation
    Patent number: 6348209
    Abstract: A formulation, method, and apparatus for treating neoplasms such as cancer by administering a pharmaceutically effective amount of highly toxic composition by inhalation, wherein the composition is a non-encapsulated antineoplastic drug.
    Type: Grant
    Filed: June 6, 2001
    Date of Patent: February 19, 2002
    Assignee: Battelle Pulmonary Therapeutics, Inc.
    Inventors: Michael E. Placke, Anthony R. Imondi, Michael J. Brooker, John E. Frye, Praful K. Shah, Douglas R. Flanagan, Jr., Maureen D. Donovan
  • Formulation and method for treating neoplasms by inhalation
    Publication number: 20010038827
    Abstract: A formulation, method, and apparatus for treating neoplasms such as cancer by administering a pharmaceutically effective amount of highly toxic composition by inhalation, wherein the composition is a non-encapsulated antineoplastic drug.
    Type: Application
    Filed: June 6, 2001
    Publication date: November 8, 2001
    Inventors: Michael E. Placke, Anthony R. Imondi, Michael J. Brooker, John E. Frye, Praful K. Shah, Douglas R. Flanagan, Maureen D. Donovan
  • Formulation and method for treating neoplasms by inhalation
    Publication number: 20010038826
    Abstract: A formulation, method, and apparatus for treating neoplasms such as cancer by administering a pharmaceutically effective amount of highly toxic composition by inhalation, wherein the composition is a non-encapsulated antineoplastic drug.
    Type: Application
    Filed: June 6, 2001
    Publication date: November 8, 2001
    Inventors: Michael E. Placke, Anthony R. Imondi, Michael J. Brooker, John E. Frye, Praful K. Shah, Douglas R. Flanagan, Maureen D. Donovan
  • Formulation and method for treating neoplasms by inhalation
    Publication number: 20010036444
    Abstract: A formulation, method, and apparatus for treating neoplasms such as cancer by administering a pharmaceutically effective amount of highly toxic composition by inhalation, wherein the composition is a non-encapsulated antineoplastic drug.
    Type: Application
    Filed: June 6, 2001
    Publication date: November 1, 2001
    Inventors: Michael E. Placke, Anthony R. Imondi, Michael J. Brooker, John E. Frye, Praful K. Shah, Douglas R. Flanagan, Maureen D. Donovan
  • Analgesic use of benzobicyclic carboxamides
    Patent number: 5122528
    Abstract: Pyrrolidinyl derivatives of Benzofuran-7-carboximides with analgesic activity".
    Type: Grant
    Filed: April 5, 1991
    Date of Patent: June 16, 1992
    Assignee: Erbamont, Inc.
    Inventor: Anthony R. Imondi
  • Method for alleviating anxiety using benzobicyclic carboxamides
    Patent number: 5114947
    Abstract: Benzofuran--7--carboxamides with anxiolytic activity.
    Type: Grant
    Filed: December 27, 1990
    Date of Patent: May 19, 1992
    Assignee: Erbamont Inc.
    Inventor: Anthony R. Imondi
  • Pharmaceutical composition containing bile acid sequestrant enclosed in a size-exclusion membrane
    Patent number: 5091175
    Abstract: A pharmaceutical composition useful for treating hypercholesterolemia comprising a bile acid sequestrant resin such as cholestyramine and cholestipol maintained in a semipermeable water-insoluble material; wherein said semipermeable material enables bile acids from the digest tract to contact and bind to said resin while preventing substances having a higher molecular weight than bile acids from contacting said resin material. A method for treating hypercholesterolemia using the inventive composition is also disclosed.
    Type: Grant
    Filed: May 14, 1990
    Date of Patent: February 25, 1992
    Assignee: Erbamont Inc.
    Inventors: Anthony R. Imondi, Larry M. Hagerman
  • Orally active tolciclate and tolnaftate
    Patent number: 4348407
    Abstract: It has been found that fungal diseases can be effectively treated systemically by oral administration of tolciclate or tolnaftate. The drugs will generally be administered in divided daily doses in the form of tablets, capsules, syrups or suspensions.
    Type: Grant
    Filed: April 29, 1981
    Date of Patent: September 7, 1982
    Assignee: Adria Laboratories, Inc.
    Inventors: Anthony R. Imondi, Irving Shemano
  • Method for treating kidney stones
    Patent number: 4143130
    Abstract: Water soluble and colloidially water soluble polymers of carboxylic acid-containing monomers useful for treating kidney stones are disclosed.
    Type: Grant
    Filed: August 29, 1977
    Date of Patent: March 6, 1979
    Assignee: Warren-Teed Laboratories, Inc.
    Inventors: Anthony R. Imondi, Richard L. Wolgemuth
  • Safer method for dissolving gallstones combining hyodeoxycholic acid with chenodeoxycholic acids
    Patent number: 4079133
    Abstract: The administration of hyodeoxycholic acid (HDCA) with chenodeoxycholic acid (CDCA) effects a lowering of serum glutamic-oxaloacetic transaminase, serum glutamic-pyruvate transaminase and alkaline phosphatase in the blood relative to the administration of CDCA alone.
    Type: Grant
    Filed: February 6, 1976
    Date of Patent: March 14, 1978
    Assignee: Warren-Teed Laboratories, Inc.
    Inventors: David T. Drees, Anthony R. Imondi